Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2017

18.04.2017 | Original Research Article

VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis

verfasst von: M. Janáky, Á. Jánossy, G. Horváth, G. Benedek, G. Braunitzer

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Visual electrophysiology is routinely used to detect the visual complications of multiple sclerosis, but the analysis mostly focuses on visual evoked potential (VEP) and especially the P100 component. Our goal was to analyze the components and waveform alterations of VEPs and pattern electroretinograms (PERGs) in patients with multiple sclerosis (MS) with good vision.

Methods

The main VEP and PERG components of 85 patients with MS were analyzed in two groups: 38 patients who had optic neuritis in their history (ON group) and 47 patients who had never had optic neuritis (MS group). The results were compared against a control group of 47 healthy subjects.

Results

Both VEP and PERG alterations occurred in a greater number of patients than expected, and these alterations were not necessarily linked to ON in the history or a deterioration of visual acuity.

Conclusions

Both VEP and PERG can detect dysfunction in the visual system in MS, even if the patient has no subjective symptoms. Even if PERG is not routinely used in neuro-ophthalmology, the results suggest that PERG assessment may provide useful information describing the retinal defect in MS.
Literatur
2.
Zurück zum Zitat Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133(1):1–9CrossRefPubMed Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133(1):1–9CrossRefPubMed
3.
Zurück zum Zitat Sand T, White LR, Hagen K, Stovner LJ (2009) Visual evoked potential and spatial frequency in migraine: a longitudinal study. Acta Neurol Scand Suppl 189:33–37CrossRef Sand T, White LR, Hagen K, Stovner LJ (2009) Visual evoked potential and spatial frequency in migraine: a longitudinal study. Acta Neurol Scand Suppl 189:33–37CrossRef
4.
Zurück zum Zitat Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D et al (2005) Identification of the neural sources of the pattern-reversal VEP. Neuroimage 24(3):874–886CrossRefPubMed Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D et al (2005) Identification of the neural sources of the pattern-reversal VEP. Neuroimage 24(3):874–886CrossRefPubMed
5.
Zurück zum Zitat Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124(Pt 9):1813–1820CrossRefPubMed Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124(Pt 9):1813–1820CrossRefPubMed
6.
Zurück zum Zitat Sartucci F, Orlandi G, Lucetti C, Bonuccelli U, Murri L, Orsini C et al (2003) Changes in pattern electroretinograms to equiluminant red–green and blue–yellow gratings in patients with early Parkinson’s disease. J Clin Neurophysiol 20(5):375–381CrossRefPubMed Sartucci F, Orlandi G, Lucetti C, Bonuccelli U, Murri L, Orsini C et al (2003) Changes in pattern electroretinograms to equiluminant red–green and blue–yellow gratings in patients with early Parkinson’s disease. J Clin Neurophysiol 20(5):375–381CrossRefPubMed
7.
Zurück zum Zitat Ungerleider LG, Haxby JV (1994) ‘What’ and ‘where’ in the human brain. Curr Opin Neurobiol 4(2):157–165CrossRefPubMed Ungerleider LG, Haxby JV (1994) ‘What’ and ‘where’ in the human brain. Curr Opin Neurobiol 4(2):157–165CrossRefPubMed
8.
Zurück zum Zitat Goodale MA, Milner AD (1992) Separate visual pathways for perception and action. Trends Neurosci 15(1):20–25CrossRefPubMed Goodale MA, Milner AD (1992) Separate visual pathways for perception and action. Trends Neurosci 15(1):20–25CrossRefPubMed
9.
Zurück zum Zitat Chan JW (2012) Recent advances in optic neuritis related to multiple sclerosis. Acta Ophthalmol 90(3):203–209CrossRefPubMed Chan JW (2012) Recent advances in optic neuritis related to multiple sclerosis. Acta Ophthalmol 90(3):203–209CrossRefPubMed
10.
Zurück zum Zitat Petzold A (2016) Optical coherence tomography to assess neurodegeneration in multiple sclerosis. Methods Mol Biol 1304:131–141CrossRefPubMed Petzold A (2016) Optical coherence tomography to assess neurodegeneration in multiple sclerosis. Methods Mol Biol 1304:131–141CrossRefPubMed
11.
Zurück zum Zitat Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932CrossRefPubMed Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932CrossRefPubMed
12.
Zurück zum Zitat Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 20(4):531–561CrossRefPubMed Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 20(4):531–561CrossRefPubMed
14.
Zurück zum Zitat Sorensen TL, Frederiksen JL, Bronnum-Hansen H, Petersen HC (1999) Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology. 53(3):473–478CrossRefPubMed Sorensen TL, Frederiksen JL, Bronnum-Hansen H, Petersen HC (1999) Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology. 53(3):473–478CrossRefPubMed
15.
Zurück zum Zitat Engell T, Trojaborg W, Raun NE (1987) Subclinical optic neuropathy in multiple sclerosis. A neuro-ophthalmological investigation by means of visually evoked response, Farnworth-Munsell 100 Hue test and Ishihara test and their diagnostic value. Acta Ophthalmol (Copenh) 65(6):735–740CrossRef Engell T, Trojaborg W, Raun NE (1987) Subclinical optic neuropathy in multiple sclerosis. A neuro-ophthalmological investigation by means of visually evoked response, Farnworth-Munsell 100 Hue test and Ishihara test and their diagnostic value. Acta Ophthalmol (Copenh) 65(6):735–740CrossRef
16.
Zurück zum Zitat Brecelj J, Strucl M, Hawlina M (1990) Central fiber contribution to W-shaped visual evoked potentials in patients with optic neuritis. Doc Ophthalmol 75(2):155–163CrossRefPubMed Brecelj J, Strucl M, Hawlina M (1990) Central fiber contribution to W-shaped visual evoked potentials in patients with optic neuritis. Doc Ophthalmol 75(2):155–163CrossRefPubMed
17.
Zurück zum Zitat Rousseff RT, Tzvetanov P, Rousseva MA (2005) The bifid visual evoked potential-normal variant or a sign of demyelination? Clin Neurol Neurosurg 107(2):113–116CrossRefPubMed Rousseff RT, Tzvetanov P, Rousseva MA (2005) The bifid visual evoked potential-normal variant or a sign of demyelination? Clin Neurol Neurosurg 107(2):113–116CrossRefPubMed
18.
Zurück zum Zitat Murray TJ (2009) The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci 277(Suppl 1):S3–S8CrossRefPubMed Murray TJ (2009) The history of multiple sclerosis: the changing frame of the disease over the centuries. J Neurol Sci 277(Suppl 1):S3–S8CrossRefPubMed
19.
Zurück zum Zitat Greenfield J, King L (1936) Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 59(4):445–458CrossRef Greenfield J, King L (1936) Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 59(4):445–458CrossRef
20.
Zurück zum Zitat Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69(22):2085–2092CrossRefPubMed Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69(22):2085–2092CrossRefPubMed
21.
Zurück zum Zitat Bock M, Brandt AU, Dorr J, Kraft H, Weinges-Evers N, Gaede G et al (2010) Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg 112(8):647–652CrossRefPubMed Bock M, Brandt AU, Dorr J, Kraft H, Weinges-Evers N, Gaede G et al (2010) Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg 112(8):647–652CrossRefPubMed
22.
Zurück zum Zitat Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393–399CrossRefPubMed Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393–399CrossRefPubMed
23.
Zurück zum Zitat Peterson J, Kidd D, Trapp B (2005) Axonal degeneration in multiple sclerosis: the histopathological evidence. In: Waxman S (ed) Multiple sclerosis as a neuronal disease. Elsevier, Amsterdam, pp 165–184CrossRef Peterson J, Kidd D, Trapp B (2005) Axonal degeneration in multiple sclerosis: the histopathological evidence. In: Waxman S (ed) Multiple sclerosis as a neuronal disease. Elsevier, Amsterdam, pp 165–184CrossRef
24.
Zurück zum Zitat Compston A (2004) Mechanisms of axon-glial injury of the optic nerve. Eye (Lond) 18(11):1182–1187CrossRef Compston A (2004) Mechanisms of axon-glial injury of the optic nerve. Eye (Lond) 18(11):1182–1187CrossRef
25.
Zurück zum Zitat Cavanagh JB (1964) The significance of the “dying back” process in experimental and human neurological disease. Int Rev Exp Pathol 3:219–267PubMed Cavanagh JB (1964) The significance of the “dying back” process in experimental and human neurological disease. Int Rev Exp Pathol 3:219–267PubMed
26.
Zurück zum Zitat Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH et al (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317CrossRefPubMed Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH et al (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317CrossRefPubMed
27.
Zurück zum Zitat Sriram P, Graham SL, Wang C, Yiannikas C, Garrick R, Klistorner A (2012) Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 53(3):1271–1275CrossRefPubMed Sriram P, Graham SL, Wang C, Yiannikas C, Garrick R, Klistorner A (2012) Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 53(3):1271–1275CrossRefPubMed
28.
Zurück zum Zitat Celesia GG, Kaufman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve. Arch Neurol 43(12):1247–1252CrossRefPubMed Celesia GG, Kaufman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve. Arch Neurol 43(12):1247–1252CrossRefPubMed
29.
Zurück zum Zitat Stefano E, Cupini LM, Rizzo P, Pierelli F, Rizzo PA (1991) Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis. Acta Neurol Belg 91(1):20–28PubMed Stefano E, Cupini LM, Rizzo P, Pierelli F, Rizzo PA (1991) Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis. Acta Neurol Belg 91(1):20–28PubMed
30.
Zurück zum Zitat Smith KJ (2006) Axonal protection in multiple sclerosis—A particular need during remyelination? Brain 129(Pt 12):3147–3149CrossRefPubMed Smith KJ (2006) Axonal protection in multiple sclerosis—A particular need during remyelination? Brain 129(Pt 12):3147–3149CrossRefPubMed
31.
Zurück zum Zitat Keough MB, Yong VW (2013) Remyelination therapy for multiple sclerosis. Neurotherapeutics 10(1):44–54CrossRefPubMed Keough MB, Yong VW (2013) Remyelination therapy for multiple sclerosis. Neurotherapeutics 10(1):44–54CrossRefPubMed
Metadaten
Titel
VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis
verfasst von
M. Janáky
Á. Jánossy
G. Horváth
G. Benedek
G. Braunitzer
Publikationsdatum
18.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2017
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-017-9589-7

Weitere Artikel der Ausgabe 3/2017

Documenta Ophthalmologica 3/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.